Codes / ICD10CM / H16.40

H16.40 Unspecified corneal neovascularization

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Unspecified corneal neovascularization

Summary

Unspecified corneal neovascularization refers to the abnormal growth of blood vessels onto the cornea, the clear front surface of the eye, without further specification of the underlying cause. This condition can impair vision and may result from various factors, including inflammation, injury, or ocular diseases. Evaluation is necessary to determine the cause and appropriate management.

Causes

Corneal neovascularization can be triggered by inflammation, infection, or injury to the cornea. Common causes include chronic dry eye, contact lens wear, ocular surgery, or conditions like uveitis. It may also develop secondary to corneal edema, chemical burns, or autoimmune disorders affecting the eye.

Risk Factors

  • Prolonged contact lens use, especially with poor hygiene.
  • History of eye trauma or surgery.
  • Chronic ocular inflammation or infection.
  • Underlying systemic conditions like diabetes or autoimmune diseases.
  • Use of topical medications that disrupt corneal health.

Symptoms

  • Blurred or reduced vision.
  • Eye redness or irritation.
  • Sensitivity to light (photophobia).
  • A feeling of a foreign object in the eye.
  • Visible blood vessels on the cornea (may be observed during exam).

Diagnosis

Diagnosis involves a comprehensive eye exam, including slit-lamp microscopy to assess the extent of vascular growth. Additional tests, such as corneal topography or angiography, may be used to evaluate the depth and pattern of neovascularization. The underlying cause is investigated to guide treatment.

Treatment Options

Treatment focuses on addressing the underlying cause and reducing vascular growth. Options may include anti-inflammatory medications, lubricating eye drops, or procedures to block abnormal vessel formation. In severe cases, surgical intervention or laser therapy may be considered.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of the condition. Early intervention can help prevent vision loss, but recurrent or progressive neovascularization may lead to complications. Regular follow-up with an eye care provider is essential to monitor changes and adjust treatment as needed.

Complications

  • Permanent vision impairment due to corneal scarring.
  • Increased risk of corneal infections.
  • Reduced effectiveness of future eye surgeries or transplants.
  • Chronic eye discomfort or irritation.

Lifestyle & Prevention

  • Maintain good eye hygiene, especially with contact lens use.
  • Protect the eyes from injury or chemical exposure.
  • Manage underlying conditions like dry eye or autoimmune diseases.
  • Avoid smoking, which can worsen ocular inflammation.
  • Use prescribed eye drops as directed to reduce irritation.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, severe eye pain, or increased redness. Prompt evaluation is necessary if symptoms worsen or new symptoms develop, such as discharge or sensitivity to light.

Tips for Medical Coders

When coding H16.40 (Unspecified corneal neovascularization), ensure documentation supports the absence of a specified cause. Include details about the extent of vascular growth, associated symptoms, and any underlying conditions if known. Verify that the diagnosis aligns with clinical findings and that no more specific code applies.

Book a walkthrough

H16.40 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.